APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amifampridine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amifampridine Industry Growth and Trends Forecast to 2032

19 December 2025102 pages

Choose your research edition.

Industry ResearchAmifampridine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Amifampridine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Amifampridine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amifampridine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Amifampridine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Amifampridine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amifampridine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amifampridine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amifampridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amifampridine include BioMarin Pharmaceutical, Biosynth AG, BLD Pharm, BroadPharm, CSNpharm, Founder Pharma, Glenmark Pharmaceuticals, Innovapharm and Jacobus Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amifampridine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amifampridine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amifampridine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amifampridine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amifampridine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amifampridine Market by Company

BioMarin Pharmaceutical

Biosynth AG

BLD Pharm

BroadPharm

CSNpharm

Founder Pharma

Glenmark Pharmaceuticals

Innovapharm

Jacobus Pharmaceutical

Norris Pharm

Unichem

Wockhardt

Merck

Amifampridine Segment by Type

Generic

Patent

Amifampridine Segment by Application

Myasthenia Gravis

Potassium Channel Blocker

Amifampridine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifampridine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amifampridine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifampridine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amifampridine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amifampridine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Generic Table 2. Major Company of Patent Table 3. Global Amifampridine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Amifampridine Sales by Type (2021-2026) & (K Units) Table 5. Global Amifampridine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Amifampridine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Amifampridine Sales Market Share in Value by Type (2021-2026) Table 8. Global Amifampridine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Amifampridine Sales by Type (2027-2032) & (K Units) Table 10. Global Amifampridine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Amifampridine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Amifampridine Sales Market Share in Value by Type (2027-2032) Table 13. Global Amifampridine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Amifampridine Sales by Type (2021-2026) & (K Units) Table 15. North America Amifampridine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Amifampridine Sales by Type (2021-2026) & (K Units) Table 17. Europe Amifampridine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Amifampridine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Amifampridine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Amifampridine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Amifampridine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Amifampridine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Amifampridine Sales by Type (2021-2026) & (US$ Million) Table 24. Amifampridine Industry Trends Table 25. Amifampridine Industry Drivers Table 26. Amifampridine Industry Opportunities and Challenges Table 27. Amifampridine Industry Restraints Table 28. Global Amifampridine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Amifampridine Revenue Market Share by Company (2021-2026) Table 30. Global Amifampridine Sales by Company (2021-2026) & (K Units) Table 31. Global Amifampridine Sales Share by Company (2021-2026) Table 32. Global Amifampridine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Amifampridine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Amifampridine Major Company Production Sites and Headquarters Table 35. Global Amifampridine Company, Product Type & Application Table 36. Global Amifampridine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Amifampridine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Amifampridine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Amifampridine Sales by Region (2021-2026) & (K Units) Table 41. Global Amifampridine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Amifampridine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Amifampridine Sales Market Share in Value by Region (2021-2026) Table 44. Global Amifampridine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Amifampridine Sales by Region (2027-2032) & (K Units) Table 46. Global Amifampridine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Amifampridine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Amifampridine Sales Market Share in Value by Region (2027-2032) Table 49. Global Amifampridine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Amifampridine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Amifampridine Sales by Application (2021-2026) & (K Units) Table 52. Global Amifampridine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Amifampridine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Amifampridine Sales Market Share in Value by Application (2021-2026) Table 55. Global Amifampridine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Amifampridine Sales by Application (2027-2032) & (K Units) Table 57. Global Amifampridine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Amifampridine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Amifampridine Sales Market Share in Value by Application (2027-2032) Table 60. Global Amifampridine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Amifampridine Sales by Application (2021-2026) & (K Units) Table 62. North America Amifampridine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Amifampridine Sales by Application (2021-2026) & (K Units) Table 64. Europe Amifampridine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Amifampridine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Amifampridine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Amifampridine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Amifampridine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Amifampridine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Amifampridine Sales by Application (2021-2026) & (US$ Million) Table 71. BioMarin Pharmaceutical Company Information Table 72. BioMarin Pharmaceutical Business Overview Table 73. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. BioMarin Pharmaceutical Amifampridine Product Portfolio Table 75. BioMarin Pharmaceutical Recent Development Table 76. Biosynth AG Company Information Table 77. Biosynth AG Business Overview Table 78. Biosynth AG Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Biosynth AG Amifampridine Product Portfolio Table 80. Biosynth AG Recent Development Table 81. BLD Pharm Company Information Table 82. BLD Pharm Business Overview Table 83. BLD Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. BLD Pharm Amifampridine Product Portfolio Table 85. BLD Pharm Recent Development Table 86. BroadPharm Company Information Table 87. BroadPharm Business Overview Table 88. BroadPharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. BroadPharm Amifampridine Product Portfolio Table 90. BroadPharm Recent Development Table 91. CSNpharm Company Information Table 92. CSNpharm Business Overview Table 93. CSNpharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. CSNpharm Amifampridine Product Portfolio Table 95. CSNpharm Recent Development Table 96. Founder Pharma Company Information Table 97. Founder Pharma Business Overview Table 98. Founder Pharma Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Founder Pharma Amifampridine Product Portfolio Table 100. Founder Pharma Recent Development Table 101. Glenmark Pharmaceuticals Company Information Table 102. Glenmark Pharmaceuticals Business Overview Table 103. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Glenmark Pharmaceuticals Amifampridine Product Portfolio Table 105. Glenmark Pharmaceuticals Recent Development Table 106. Innovapharm Company Information Table 107. Innovapharm Business Overview Table 108. Innovapharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Innovapharm Amifampridine Product Portfolio Table 110. Innovapharm Recent Development Table 111. Jacobus Pharmaceutical Company Information Table 112. Jacobus Pharmaceutical Business Overview Table 113. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jacobus Pharmaceutical Amifampridine Product Portfolio Table 115. Jacobus Pharmaceutical Recent Development Table 116. Norris Pharm Company Information Table 117. Norris Pharm Business Overview Table 118. Norris Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Norris Pharm Amifampridine Product Portfolio Table 120. Norris Pharm Recent Development Table 121. Unichem Company Information Table 122. Unichem Business Overview Table 123. Unichem Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Unichem Amifampridine Product Portfolio Table 125. Unichem Recent Development Table 126. Wockhardt Company Information Table 127. Wockhardt Business Overview Table 128. Wockhardt Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Wockhardt Amifampridine Product Portfolio Table 130. Wockhardt Recent Development Table 131. Merck Company Information Table 132. Merck Business Overview Table 133. Merck Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Merck Amifampridine Product Portfolio Table 135. Merck Recent Development Table 136. North America Amifampridine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Amifampridine Sales by Country (2021-2026) & (K Units) Table 138. North America Amifampridine Sales Market Share by Country (2021-2026) Table 139. North America Amifampridine Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Amifampridine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Amifampridine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Amifampridine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Amifampridine Market Share by Country (2021-2026) Table 144. North America Amifampridine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Amifampridine Market Share Forecast by Country (2027-2032) Table 146. Europe Amifampridine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Amifampridine Sales by Country (2021-2026) & (K Units) Table 148. Europe Amifampridine Sales Market Share by Country (2021-2026) Table 149. Europe Amifampridine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Amifampridine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Amifampridine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Amifampridine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Amifampridine Market Share by Country (2021-2026) Table 154. Europe Amifampridine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Amifampridine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Amifampridine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Amifampridine Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Amifampridine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Amifampridine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Amifampridine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Amifampridine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Amifampridine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Amifampridine Market Share by Country (2021-2026) Table 164. Asia-Pacific Amifampridine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Amifampridine Market Share Forecast by Country (2027-2032) Table 166. Latin America Amifampridine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Amifampridine Sales by Country (2021-2026) & (K Units) Table 168. Latin America Amifampridine Sales Market Share by Country (2021-2026) Table 169. Latin America Amifampridine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Amifampridine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Amifampridine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Amifampridine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Amifampridine Market Share by Country (2021-2026) Table 174. Latin America Amifampridine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Amifampridine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Amifampridine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Amifampridine Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Amifampridine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Amifampridine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Amifampridine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Amifampridine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Amifampridine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Amifampridine Market Share by Country (2021-2026) Table 184. Middle East and Africa Amifampridine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Amifampridine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Amifampridine Distributors List Table 189. Amifampridine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Amifampridine Image Figure 2. Global Amifampridine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amifampridine Market Size (2021-2032) & (US$ Million) Figure 4. Global Amifampridine Sales (2021-2032) & (K Units) Figure 5. Generic Image Figure 6. Global Generic Sales YoY Growth (2021-2032) & (K Units) Figure 7. Patent Image Figure 8. Global Patent Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Amifampridine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Amifampridine Market Share by Type 2025 VS 2032 Figure 11. North America Amifampridine Sales Market Share in Volume by Type in 2025 Figure 12. North America Amifampridine Sales Market Share in Value by Type in 2025 Figure 13. Europe Amifampridine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Amifampridine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Amifampridine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Amifampridine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Amifampridine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Amifampridine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Amifampridine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Amifampridine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Amifampridine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Myasthenia Gravis Image Figure 24. Global Myasthenia Gravis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Potassium Channel Blocker Image Figure 26. Global Potassium Channel Blocker Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Amifampridine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Amifampridine Market Share by Application 2025 VS 2032 Figure 29. North America Amifampridine Sales Market Share in Volume by Application in 2025 Figure 30. North America Amifampridine Sales Market Share in Value by Application in 2025 Figure 31. Europe Amifampridine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Amifampridine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Amifampridine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Amifampridine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Amifampridine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Amifampridine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Amifampridine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Amifampridine Sales Market Share in Value by Application in 2025 Figure 39. North America Amifampridine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Amifampridine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Amifampridine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Amifampridine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Amifampridine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Amifampridine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Amifampridine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Amifampridine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Amifampridine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Amifampridine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Amifampridine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Amifampridine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Amifampridine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Amifampridine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Amifampridine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Amifampridine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Amifampridine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Amifampridine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Amifampridine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Amifampridine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Amifampridine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Amifampridine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Generic
  • Patent
Applications
  • Myasthenia Gravis
  • Potassium Channel Blocker
Companies covered
  • BioMarin Pharmaceutical
  • Biosynth AG
  • BLD Pharm
  • BroadPharm
  • CSNpharm
  • Founder Pharma
  • Glenmark Pharmaceuticals
  • Innovapharm
  • Jacobus Pharmaceutical
  • Norris Pharm
  • Unichem
  • Wockhardt
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amifampridine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amifampridine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amifampridine Market by Type
  6. 1.3.1 Generic
  7. 1.3.2 Patent
  8. 1.4 Global Amifampridine Market Size by Type
  9. 1.4.1 Global Amifampridine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Amifampridine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Amifampridine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Amifampridine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Amifampridine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Amifampridine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Amifampridine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Amifampridine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amifampridine Industry Trends
  2. 2.2 Amifampridine Industry Drivers
  3. 2.3 Amifampridine Industry Opportunities and Challenges
  4. 2.4 Amifampridine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amifampridine Revenue (2021-2026)
  2. 3.2 Global Top Players by Amifampridine Sales (2021-2026)
  3. 3.3 Global Top Players by Amifampridine Price (2021-2026)
  4. 3.4 Global Amifampridine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amifampridine Major Company Production Sites & Headquarters
  6. 3.6 Global Amifampridine Company, Product Type & Application
  7. 3.7 Global Amifampridine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amifampridine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amifampridine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amifampridine Tier 1, Tier 2, and Tier 3
4 Amifampridine Regional Status and Outlook
  1. 4.1 Global Amifampridine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amifampridine Historic Market Size by Region
  3. 4.2.1 Global Amifampridine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amifampridine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amifampridine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amifampridine Forecasted Market Size by Region
  7. 4.3.1 Global Amifampridine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amifampridine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amifampridine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amifampridine by Application
  1. 5.1 Amifampridine Market by Application
  2. 5.1.1 Myasthenia Gravis
  3. 5.1.2 Potassium Channel Blocker
  4. 5.2 Global Amifampridine Market Size by Application
  5. 5.2.1 Global Amifampridine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Amifampridine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Amifampridine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Amifampridine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Amifampridine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Amifampridine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Amifampridine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Amifampridine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BioMarin Pharmaceutical
  2. 6.1.1 BioMarin Pharmaceutical Company Information
  3. 6.1.2 BioMarin Pharmaceutical Business Overview
  4. 6.1.3 BioMarin Pharmaceutical Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BioMarin Pharmaceutical Amifampridine Product Portfolio
  6. 6.1.5 BioMarin Pharmaceutical Recent Developments
  7. 6.2 Biosynth AG
  8. 6.2.1 Biosynth AG Company Information
  9. 6.2.2 Biosynth AG Business Overview
  10. 6.2.3 Biosynth AG Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biosynth AG Amifampridine Product Portfolio
  12. 6.2.5 Biosynth AG Recent Developments
  13. 6.3 BLD Pharm
  14. 6.3.1 BLD Pharm Company Information
  15. 6.3.2 BLD Pharm Business Overview
  16. 6.3.3 BLD Pharm Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BLD Pharm Amifampridine Product Portfolio
  18. 6.3.5 BLD Pharm Recent Developments
  19. 6.4 BroadPharm
  20. 6.4.1 BroadPharm Company Information
  21. 6.4.2 BroadPharm Business Overview
  22. 6.4.3 BroadPharm Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BroadPharm Amifampridine Product Portfolio
  24. 6.4.5 BroadPharm Recent Developments
  25. 6.5 CSNpharm
  26. 6.5.1 CSNpharm Company Information
  27. 6.5.2 CSNpharm Business Overview
  28. 6.5.3 CSNpharm Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSNpharm Amifampridine Product Portfolio
  30. 6.5.5 CSNpharm Recent Developments
  31. 6.6 Founder Pharma
  32. 6.6.1 Founder Pharma Company Information
  33. 6.6.2 Founder Pharma Business Overview
  34. 6.6.3 Founder Pharma Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Founder Pharma Amifampridine Product Portfolio
  36. 6.6.5 Founder Pharma Recent Developments
  37. 6.7 Glenmark Pharmaceuticals
  38. 6.7.1 Glenmark Pharmaceuticals Company Information
  39. 6.7.2 Glenmark Pharmaceuticals Business Overview
  40. 6.7.3 Glenmark Pharmaceuticals Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Glenmark Pharmaceuticals Amifampridine Product Portfolio
  42. 6.7.5 Glenmark Pharmaceuticals Recent Developments
  43. 6.8 Innovapharm
  44. 6.8.1 Innovapharm Company Information
  45. 6.8.2 Innovapharm Business Overview
  46. 6.8.3 Innovapharm Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Innovapharm Amifampridine Product Portfolio
  48. 6.8.5 Innovapharm Recent Developments
  49. 6.9 Jacobus Pharmaceutical
  50. 6.9.1 Jacobus Pharmaceutical Company Information
  51. 6.9.2 Jacobus Pharmaceutical Business Overview
  52. 6.9.3 Jacobus Pharmaceutical Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jacobus Pharmaceutical Amifampridine Product Portfolio
  54. 6.9.5 Jacobus Pharmaceutical Recent Developments
  55. 6.10 Norris Pharm
  56. 6.10.1 Norris Pharm Company Information
  57. 6.10.2 Norris Pharm Business Overview
  58. 6.10.3 Norris Pharm Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Norris Pharm Amifampridine Product Portfolio
  60. 6.10.5 Norris Pharm Recent Developments
  61. 6.11 Unichem
  62. 6.11.1 Unichem Company Information
  63. 6.11.2 Unichem Business Overview
  64. 6.11.3 Unichem Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Unichem Amifampridine Product Portfolio
  66. 6.11.5 Unichem Recent Developments
  67. 6.12 Wockhardt
  68. 6.12.1 Wockhardt Company Information
  69. 6.12.2 Wockhardt Business Overview
  70. 6.12.3 Wockhardt Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Wockhardt Amifampridine Product Portfolio
  72. 6.12.5 Wockhardt Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck Amifampridine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Merck Amifampridine Product Portfolio
  78. 6.13.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Amifampridine Sales by Country
  2. 7.1.1 North America Amifampridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amifampridine Sales by Country (2021-2026)
  4. 7.1.3 North America Amifampridine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amifampridine Market Size by Country
  6. 7.2.1 North America Amifampridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amifampridine Market Size by Country (2021-2026)
  8. 7.2.3 North America Amifampridine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amifampridine Sales by Country
  2. 8.1.1 Europe Amifampridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amifampridine Sales by Country (2021-2026)
  4. 8.1.3 Europe Amifampridine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amifampridine Market Size by Country
  6. 8.2.1 Europe Amifampridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amifampridine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amifampridine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amifampridine Sales by Country
  2. 9.1.1 Asia-Pacific Amifampridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amifampridine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amifampridine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amifampridine Market Size by Country
  6. 9.2.1 Asia-Pacific Amifampridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amifampridine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amifampridine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amifampridine Sales by Country
  2. 10.1.1 South America Amifampridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amifampridine Sales by Country (2021-2026)
  4. 10.1.3 South America Amifampridine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amifampridine Market Size by Country
  6. 10.2.1 South America Amifampridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amifampridine Market Size by Country (2021-2026)
  8. 10.2.3 South America Amifampridine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amifampridine Sales by Country
  2. 11.1.1 Middle East and Africa Amifampridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amifampridine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amifampridine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amifampridine Market Size by Country
  6. 11.2.1 Middle East and Africa Amifampridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amifampridine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amifampridine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amifampridine Value Chain Analysis
  2. 12.1.1 Amifampridine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amifampridine Production Mode & Process
  7. 12.2 Amifampridine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amifampridine Distributors
  10. 12.2.3 Amifampridine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst